- Trials with a EudraCT protocol (20)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
20 result(s) found for: Light Ray.
Displaying page 1 of 1.
EudraCT Number: 2008-004149-27 | Sponsor Protocol Number: I13106870 | Start Date*: 2009-01-06 | |||||||||||
Sponsor Name:GlaxoSmithKline Research and Development Ltd | |||||||||||||
Full Title: A Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Repeat-Dose study to evaluate the Efficacy and Safety of Intravenous GSK679586 in Patients with Severe Asthma | |||||||||||||
Medical condition: Severe asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) DE (Completed) FR (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-006227-31 | Sponsor Protocol Number: 0881X1-4503 | Start Date*: 2009-01-09 |
Sponsor Name:Medical Faculty, Otto-von-Guericke-University Magdeburg | ||
Full Title: Inflammatory Topoproteome of Psoriasis under Etanercept Treatment | ||
Medical condition: Patients with a severe psoriasis will be treated with Enbrel (Etanercept) 2 x 50 mg s.c. per week over 12 weeks (n = 6 patients). The treatment follows rigorously the approved label of the drug. Th... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-001362-32 | Sponsor Protocol Number: Prot-06032007 | Start Date*: 2008-03-03 | |||||||||||
Sponsor Name:University Hospitals Of Leicester NHS Trust | |||||||||||||
Full Title: The use of non-ionic contrast media to clear corneal scars | |||||||||||||
Medical condition: Will plan to investigate patients who would benefit from cataract surgery but whom have corneal scarring which would make surgery difficult. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-018279-99 | Sponsor Protocol Number: HUM07-066 | Start Date*: 2010-05-05 |
Sponsor Name:Faculty of Medicine, Otto-von-Guericke-University Magdeburg | ||
Full Title: Skin Topoproteome under Adalimumab (Humira®) Treatment in Patients with Moderate to Severe Psoriasis | ||
Medical condition: Disease under investigation: Adult patients of both genders with moderate to severe chronic plaque psoriasis who failed to respond to or who have a contraindication to, or are intolerant to other s... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-007170-30 | Sponsor Protocol Number: TUD-Psslan-031 | Start Date*: 2008-06-03 |
Sponsor Name:Technical University of Dresden, faculty of medicine | ||
Full Title: Untersuchung des Phänotyps und der Funktion proinflammatorischer dendritischer Zellen während einer Therapie der Psoriasis vulgaris mit einem TNFalpha Antagonisten Investigation of phenotype and f... | ||
Medical condition: Psoriasis vulgaris | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2008-008599-15 | Sponsor Protocol Number: RV-MM-EMN-441 | Start Date*: 2009-04-20 |
Sponsor Name:FONDAZIONE NEOPLASIE SANGUE ONLUS | ||
Full Title: A PHASE 3, MULTICENTRE, RANDOMIZED, CONTROLLED STUDY TO DETERMINE THE EFFICACY AND SAFETY OF CYCLOPHOSPHAMIDE, LENALIDOMIDE AND DEXAMETHASONE (CRD) versus MELPHALAN (200 mg/m2) FOLLOWED BY STEM CEL... | ||
Medical condition: Multiple myeloma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: IT (Ongoing) CZ (Completed) SK (Ongoing) HU (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001645-41 | Sponsor Protocol Number: 19-339A(3) | Start Date*: 2020-03-27 | |||||||||||
Sponsor Name:Memorial Sloan Kettering Cancer center | |||||||||||||
Full Title: Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone vs Carfilzomib, Lenalidomide, and Dexamethasone vs Bortezomib, Lenalidomide, and Dexamethasone in Newly-Diagnosed Multiple Myeloma: A Clin... | |||||||||||||
Medical condition: Newly diagnosed Multiple Myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000085-39 | Sponsor Protocol Number: P04271 | Start Date*: 2005-09-08 | |||||||||||
Sponsor Name:Schering-Plough Research Institute | |||||||||||||
Full Title: An Open-Label, Randomized Efficacy and Safety Study of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis | |||||||||||||
Medical condition: Moderate to severe psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) PT (Completed) DE (Completed) GB (Completed) SE (Completed) ES (Completed) GR (Completed) AT (Completed) FI (Completed) BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000411-15 | Sponsor Protocol Number: CBHQ880A2102 | Start Date*: 2009-05-28 | |||||||||||
Sponsor Name:Novartis Farmacéutica, S.A | |||||||||||||
Full Title: Estudio de Fase Ib, multicéntrico, de determinación de dosis, con un fase II doble ciego, controlado con placebo, aleatorizado, adaptativo, que utiliza varias dosis IV repetidas de BHQ880 en combin... | |||||||||||||
Medical condition: Mieloma Múltiple refractario o en recaída. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) IT (Completed) GB (Prematurely Ended) DE (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000535-26 | Sponsor Protocol Number: P05133 | Start Date*: 2007-06-04 | |||||||||||
Sponsor Name:SCHERING-PLOUGH | |||||||||||||
Full Title: SwiTching from etAnercept to iNfliximab in the treatment of moderate to severe psoriasis; a multi-center, open label trial evaluating the efficacy, tOlerance and safety (TANGO) | |||||||||||||
Medical condition: Patients with moderate to severe psoriasi. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004493-22 | Sponsor Protocol Number: AVT04-GL-301 | Start Date*: 2021-04-20 | |||||||||||
Sponsor Name:Alvotech Swiss AG | |||||||||||||
Full Title: A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Ustekinumab (AVT04) and Stelara® in Patients With Moderate ... | |||||||||||||
Medical condition: Moderate to Severe Chronic Plaque-type Psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-002188-31 | Sponsor Protocol Number: HLX14-002-PMOP301 | Start Date*: 2022-11-25 | |||||||||||
Sponsor Name:Shanghai Henlius Biotech, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, International Multicenter, Parallel-Controlled Phase III Clinical Study to Evaluate Recombinant Anti-RANKL Human Monoclonal Antibody Injection (HLX14) Versus Denosumab I... | |||||||||||||
Medical condition: Osteoporosis at High Risk of Fracture | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004280-32 | Sponsor Protocol Number: AG10-301 | Start Date*: 2019-05-10 | |||||||||||
Sponsor Name:Eidos Therapeutics, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of AG10 in Subjects with Symptomatic Transthyretin Amyloid Cardiomyopathy (ATTRIBUTE-CM Trial) | |||||||||||||
Medical condition: Symptomatic Transthyretin Amyloid Cardiomyopathy (ATTR-CM) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DK (Completed) IE (Completed) PT (Completed) ES (Ongoing) NL (Completed) BE (Completed) HU (Completed) PL (Completed) GR (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001243-28 | Sponsor Protocol Number: P04320 | Start Date*: 2005-08-03 | |||||||||||
Sponsor Name:essex pharma GmbH | |||||||||||||
Full Title: Study to determine the non inferiority of GROUP I (“high need”) compared to GROUP II (“low need”) concerning the efficacy of infliximab with respect to safety and tolerability in patients suffering... | |||||||||||||
Medical condition: Moderate to severe plaque-type psoriaris (psoriasis vulgaris). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023901-36 | Sponsor Protocol Number: UHK-GMD-LOA-04 | Start Date*: 2011-04-12 |
Sponsor Name:Faculty of Medicine, Otto-von-Guericke-University, Magdeburg | ||
Full Title: Psoriasis-topoproteome under ustekinumab treatment (PIROUETTE-Study) - as an interventional observation study (phase IV) within approved label and indication and with minimal invasive taking of ski... | ||
Medical condition: STELARA™ as IMP will be used in all relevant aspects (indication, contraindications, dosing) completely within the approved label, namely for the treatment of adult patients with moderate to severe... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-001051-39 | Sponsor Protocol Number: FMG-MM-02 | Start Date*: 2012-11-15 | |||||||||||
Sponsor Name:Kuopio University Hospital, Clinic of Internal Medicine/Center of Medicine | |||||||||||||
Full Title: A prospective phase II study to assess immunophenotypic remission after three-drug in-duction followed by randomized stem cell mobilization, autologous stem cell transplantation and lenalidomide ma... | |||||||||||||
Medical condition: Multiple myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003692-35 | Sponsor Protocol Number: ZKSJ0109 | Start Date*: 2019-06-13 | |||||||||||
Sponsor Name:Friedrich Schiller University Jena | |||||||||||||
Full Title: Effects of empagliflozin on diuresis and renal function in patients with acute decompensated heart failure | |||||||||||||
Medical condition: acute decompensated heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002465-35 | Sponsor Protocol Number: B3461028 | Start Date*: 2014-04-07 | |||||||||||
Sponsor Name:FoldRx Pharmaceuticals, a Pfizer Company | |||||||||||||
Full Title: A multicentre, international, phase 3, double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of daily oral dosing of tafamidis meglumine (PF-06291826)... | |||||||||||||
Medical condition: Transthyretin amyloid cardiomyopathy (TTR-CM) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) IT (Completed) ES (Completed) DE (Completed) SE (Completed) CZ (Completed) NL (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000128-16 | Sponsor Protocol Number: 2011-003 | Start Date*: 2012-07-30 | |||||||||||
Sponsor Name:Onyx Therapeutics, Inc. | |||||||||||||
Full Title: A Randomized, Open-label, Phase 3 Study of Carfilzomib Plus Dexamethasone vs Bortezomib Plus Dexamethasone in Patients With Relapsed Multiple Myeloma | |||||||||||||
Medical condition: Multiple myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) HU (Completed) DE (Completed) IT (Completed) ES (Completed) SK (Completed) GR (Completed) CZ (Completed) AT (Completed) BG (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002716-10 | Sponsor Protocol Number: 165-001 | Start Date*: 2012-11-08 | |||||||||||
Sponsor Name:Prof. Dr. Kristian Reich | |||||||||||||
Full Title: An international prospective, double-blind, placebo-controlled phase III RCT in which patients with moderate to severe psoriasis vulgaris are treated with s.c. methotrexate using an optimized treat... | |||||||||||||
Medical condition: Psoriasis vulgaris | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.